Eam Investors, LLC Profound Medical Corp. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$16.0 - $20.59 $165,280 - $212,694	-10,330 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$19.16 - $28.09 $809,184 - $1.19 Million	-42,233 Reduced 80.35%	10,330 $208,000
Q4 2020 Feb 11, 2021	BUY	$16.4 - $22.9 $862,033 - $1.2 Million	52,563 New	52,563 $1.08 Million
Q2 2020 Aug 13, 2020	SELL	$9.41 - $16.94 $598,494 - $1.08 Million	-63,602 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.88 - $19.7 $437,581 - $1.25 Million	63,602 New	63,602 $605,000

9.31M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $134M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.